Zhitong Finance App News, Shengnuo Biotech (688117.SH) issued an announcement. Meishan Huilong Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Meishan Huilong”), a wholly-owned subsidiary of the company, recently received the “Pharmaceutical Production License” and “Drug GMP Compliance Inspection Notice” approved and issued by the Sichuan Drug Administration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.